Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy

Inflammatory bowel disease (IBD) is characterised by substantial heterogeneity in treatment response. With an expanding number of therapeutic agents, identifying optimal treatment at the patient level remains a major challenge.To systematically review the available literature on predictive biomarkers of therapeutic response in IBD.An electronic literature search was performed on 30 January 2018 using MEDLINE, EMBASE and the Cochrane Library....